Life Sciences Tools & Services Contracts & Agreements
5,189 Contracts from 64 Life Sciences Tools & Services Companies
- 10x Genomics, Inc. (57 contracts)
- AbCellera Biologics Inc. (23)
- AbSci Corp (41)
- Adaptive Biotechnologies Corp (37)
- Agilent Technologies Inc (187)
- Akoya Biosciences, Inc. (29)
- Alpha Teknova, Inc. (48)
- ArcherDX, Inc. (22)
- ARQULE INC (83)
- ARYA Sciences Acquisition Corp III (49)
- Avantor, Inc. (39)
- Basis Global Technologies, Inc. (11)
- Berkeley Lights, Inc. (51)
- Bio-Matrix Scientific Group, Inc. (146)
- Bio-Rad Laboratories (42)
- Bio-Techne (95)
- BIOANALYTICAL SYSTEMS INC (143)
- BioNano Genomics, Inc (152)
- BRUKER CORP (58)
- Cambrex Corporation (35)
- CHAMPIONS ONCOLOGY, INC. (45)
- Charles River Laboratories (95)
- ChromaDex Corp. (176)
- CM Life Sciences II Inc. (59)
- Codex DNA, Inc. (50)
- CODEXIS INC (185)
- Cytek BioSciences, Inc. (24)
- ECO SCIENCE SOLUTIONS, INC. (65)
- EMMAUS LIFE SCIENCES, INC. (272)
- EVIO, INC. (99)
- FLUIDIGM CORP (181)
- HARVARD BIOSCIENCE INC (111)
- HighCape Capital Acquisition Corp. (71)
- Illumina Inc (140)
- INTERNATIONAL ISOTOPES INC (3)
- InventaBioTech Inc. (6)
- IQVIA Holdings Inc. (118)
- IsoPlexis Corp (32)
- Lifesci Acquisition II Corp. (49)
- Luminex Corporation (108)
- MARAVAI LIFESCIENCES HOLDINGS, INC. (68)
- Medpace Holdings, Inc. (38)
- Mettler Toledo (38)
- Miromatrix Medical Inc. (64)
- NanoString Technologies Inc (108)
- NEOGENOMICS INC (101)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (112)
- PerkinElmer (190)
- Personalis, Inc. (69)
- Pharma-Bio Serv, Inc. (44)
- PPD, Inc. (31)
- PRA Health Sciences (57)
- PRESSURE BIOSCIENCES INC (107)
- Quanterix Corp (77)
- RAPID MICRO BIOSYSTEMS, INC. (36)
- Repligen Corporation (76)
- Seer, Inc. (37)
- SeqLL, Inc. (93)
- Singular Genomics Systems, Inc. (35)
- Sotera Health Co (39)
- Syneos Health (132)
- Thermo Fisher Scientific (245)
- VG Acquisition Corp. (63)
- Waters Corporation (92)
- Business Finance (1,920 contracts from 64 companies)
- Business Formation (1 | 1)
- Business Operations (310 | 60)
- Human Resources (1,483 | 62)
- Intellectual Property (168 | 28)
- Mergers & Acquisitions (95 | 35)
- Real Estate (211 | 37)
- Uncategorized (1,001 | 63)
- Amendment No. 4 to Credit and Security Agreement, dated July 31, 2024, by and between the Registrant and Midcap Financial Trust (Akoya Biosciences, Inc., Filed With SEC on November 14, 2024)
- Form of Restricted Stock Agreement under the 2023 Inducement Equity Incentive Plan (HighCape Capital Acquisition Corp., Filed With SEC on November 12, 2024)
- 2023 Inducement Equity Incentive Plan, as amended (HighCape Capital Acquisition Corp., Filed With SEC on November 12, 2024)
- Offer Letter of Employment, dated as of August 22, 2024, by and between Quantum-Si Incorporated and Todd Bennett (HighCape Capital Acquisition Corp., Filed With SEC on November 12, 2024)
- Letter of Employment, dated as of August 12, 2024, by and between Quantum-Si Incorporated and John Vieceli (HighCape Capital Acquisition Corp., Filed With SEC on November 12, 2024)
- Separation and General Release Agreement (Codex DNA, Inc., Filed With SEC on November 7, 2024)
- Agreement and Plan of Merger among Staffing 360 Solutions, Inc, A36 Merger Sub Inc. and Atlantic International Corp, dated November 1, 2024 (SeqLL, Inc., Filed With SEC on November 7, 2024)
- Amended Offer Letter between the Registrant and Eric Esser dated April 17, 2024 (Codex DNA, Inc., Filed With SEC on November 7, 2024)
- Letter Agreement, dated November 7, 2024, between the Company and SB Northstar LP (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on November 7, 2024)
- Amendment No. 2 to the Commercialization and Reference Laboratory Agreement, dated September 20, 2024, by and between Personalis, Inc. and Tempus AI, Inc (Personalis, Inc., Filed With SEC on November 6, 2024)
- Form of Securities Purchase Agreement dated October 30, 2024, between Bionano Genomics, Inc. and the purchasers party thereto (BioNano Genomics, Inc, Filed With SEC on October 31, 2024)
- Form of Series D Warrant (BioNano Genomics, Inc, Filed With SEC on October 31, 2024)
- Form of Series C Warrant (BioNano Genomics, Inc, Filed With SEC on October 31, 2024)
- Tenth Amendment to Manufacturing and Supply Agreement, dated as of January 1, 2025, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on October 31, 2024)
- Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement (Non-Employee Director Form) under 2017 Incentive Award Plan (Bio-Rad Laboratories, Filed With SEC on October 31, 2024)
- Change in Control Severance Agreement by and between the Company and (CODEXIS INC, Filed With SEC on October 31, 2024)
- Change in Control Severance Agreement by and between the Company and (CODEXIS INC, Filed With SEC on October 31, 2024)
- Amendment to the Codexis, Inc. 2023 Employee Stock Purchase Plan (CODEXIS INC, Filed With SEC on October 31, 2024)
- Offer Letter by and between the Company and (CODEXIS INC, Filed With SEC on October 31, 2024)
- Offer Letter by and between the Company and (CODEXIS INC, Filed With SEC on October 31, 2024)
- Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Ken Suzuki dated September 16, 2024 (ARYA Sciences Acquisition Corp III, Filed With SEC on October 29, 2024)
- Employment Offer Letter by and between the Registrant and Adam Taich dated August 7, 2024 (10x Genomics, Inc., Filed With SEC on October 29, 2024)
- Form of 2019 Employee Stock Purchase Plan Subscription Agreement (10x Genomics, Inc., Filed With SEC on October 29, 2024)
- Form of 2019 Omnibus Incentive Plan Restricted Stock Unit Award Notice and Agreement (10x Genomics, Inc., Filed With SEC on October 29, 2024)
- Form of 2019 Omnibus Incentive Plan Stock Option Award Notice and Agreement (10x Genomics, Inc., Filed With SEC on October 29, 2024)
- Offer Letter between Nautilus Biotechnology, Inc. and Ken Suzuki dated July 5, 2024 (ARYA Sciences Acquisition Corp III, Filed With SEC on October 29, 2024)
- Form of Medpace Holdings, Inc (Medpace Holdings, Inc., Filed With SEC on October 22, 2024)
- Form of Medpace Holdings, Inc (Medpace Holdings, Inc., Filed With SEC on October 22, 2024)
- 23andMe Holding Co. Amended and Restated Employee Stock Purchase Plan (VG Acquisition Corp., Filed With SEC on October 16, 2024)
- 23andMe Holding Co. Second Amended and Restated 2021 Incentive Equity Plan (VG Acquisition Corp., Filed With SEC on October 16, 2024)
- Separation Agreement between Illumina, Inc. and Charles Dadswell, dated October 3, 2024 (Illumina Inc, Filed With SEC on October 3, 2024)
- Advisory Agreement between Illumina, Inc. and Charles Dadswell, dated October 3, 2024 (Illumina Inc, Filed With SEC on October 3, 2024)
- Amendment No. 1 to Convertible Promissory Note dated as of September 12, 2024 made by the issuer to IDC Technologes Inc (SeqLL, Inc., Filed With SEC on September 16, 2024)
- Letter dated September 16, 2024 to the shareholders of record as of September 26, 2023 (SeqLL, Inc., Filed With SEC on September 16, 2024)
- Officers Certificate, dated September 9, 2024, setting forth the terms and form of the Notes (Illumina Inc, Filed With SEC on September 9, 2024)
- Underwriting Agreement, dated September 4, 2024, between the Company and J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters... (Illumina Inc, Filed With SEC on September 9, 2024)
- Third Supplemental Indenture, dated as of September 9, 2024, between the Company and Citibank, N.A (Agilent Technologies Inc, Filed With SEC on September 9, 2024)
- Second Supplemental Indenture, dated as of September 9, 2024, between the Company and Citibank, N.A (Agilent Technologies Inc, Filed With SEC on September 9, 2024)
- Underwriting Agreement, dated September 4, 2024, among the Company, Citigroup Global Markets Inc., as underwriter, and the selling stockholders named in Schedule 2 thereto (Sotera Health Co, Filed With SEC on September 6, 2024)
- Underwriting Agreement, dated September 4, 2024, by and among the Company, BofA Securities, Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC and Wells Fargo Securities,... (Agilent Technologies Inc, Filed With SEC on September 5, 2024)
